| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 11/24/2011 | WO2011144584A1 Pyrrolopyrazine derivatives as syk and jak inhibitors |
| 11/24/2011 | WO2011143788A1 Novel glucagon like peptide analogs, composition, and method of use |
| 11/24/2011 | WO2011112229A3 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 11/24/2011 | WO2011090271A3 Composition containing litchi seed extract for preventing or treating fatty liver or obesity |
| 11/24/2011 | WO2011075539A3 Treatment of obesity or diabetes with bile acid sequestrants |
| 11/24/2011 | WO2011068703A3 Methods of modulating inflammation in preterm infants using carotenoids |
| 11/24/2011 | US20110288171 Methods of treating hypertriglyceridemia |
| 11/24/2011 | US20110288160 Treatment of Metabolic-Related Disorders Using Hypothalamic Gene Transfer of BDNF and Compositions Therefor |
| 11/24/2011 | US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 11/24/2011 | US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis |
| 11/24/2011 | US20110288153 Translation factors as anti-aging drug targets |
| 11/24/2011 | US20110288147 Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop |
| 11/24/2011 | US20110288137 Sydnonimines-specific dopamine reuptake inhibitors ad their use in treating dopamine related disorders |
| 11/24/2011 | US20110288129 Amide derivatives as trpv1 antagonists |
| 11/24/2011 | US20110288125 Novel use of piperine |
| 11/24/2011 | US20110288122 Pharmaceutical Compositions and Administrations Thereof |
| 11/24/2011 | US20110288120 Isoquinolinone derivatives as nk3 antagonists |
| 11/24/2011 | US20110288115 Treatment of vagally-mediated spectrum disorders |
| 11/24/2011 | US20110288110 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 11/24/2011 | US20110288104 Beta-3 receptor ligands and their use in therapy |
| 11/24/2011 | US20110288103 Compounds, compositions, and methods comprising 1,3,4-oxadiazole derivatives |
| 11/24/2011 | US20110288099 Compositions with reduced hepatotoxicity |
| 11/24/2011 | US20110288097 Pyrrolopyrazine Kinase Inhibitors |
| 11/24/2011 | US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 11/24/2011 | US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors |
| 11/24/2011 | US20110288087 Fused ring compound and use thereof |
| 11/24/2011 | US20110288083 Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase |
| 11/24/2011 | US20110288073 Alpha-Aminocyclolactam Ligands for G-protein Coupled Receptors, and Methods of Using Same |
| 11/24/2011 | US20110288072 Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction |
| 11/24/2011 | US20110288067 Pyrrolopyrazine Kinase Inhibitors |
| 11/24/2011 | US20110288064 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 11/24/2011 | US20110288060 apparatus and process for producing crystals |
| 11/24/2011 | US20110288057 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 11/24/2011 | US20110288056 Once daily formulations of tetracyclines |
| 11/24/2011 | US20110288052 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 11/24/2011 | US20110288051 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 11/24/2011 | US20110288034 Methods of identifying adipocyte specific genes, the genes identified, and their uses |
| 11/24/2011 | US20110288025 Biopolymer produced by fermenting the extract of soybean with folic acid and a composition containing thereof |
| 11/24/2011 | US20110288017 Apo-lipoprotein propeptide |
| 11/24/2011 | US20110288016 Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies |
| 11/24/2011 | US20110288015 Treatment of renal dysfunction and multiple myeloma using pacap compounds |
| 11/24/2011 | US20110288014 Methods and compositions for diabetes treatment and prevention |
| 11/24/2011 | US20110288013 Glycemic control for reduction of cardiovascular disease risk in diabetic patients expressing haptoglobin 2-2 |
| 11/24/2011 | US20110288012 Nutrition composition |
| 11/24/2011 | US20110288011 Peptide therapeutic conjugates and uses thereof |
| 11/24/2011 | US20110288010 Utilization of peptides as active ingredients for slimming |
| 11/24/2011 | US20110288009 Leptin and leptin analog conjugates and uses thereof |
| 11/24/2011 | US20110288004 Viral Sequences and Uses Thereof |
| 11/24/2011 | US20110288003 Amide based glucagon and superfamily peptide prodrugs |
| 11/24/2011 | US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT |
| 11/24/2011 | US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds |
| 11/24/2011 | US20110287103 Sustained-release formulations of topiramate |
| 11/24/2011 | US20110287100 Galenic Formulations of Organic Compounds |
| 11/24/2011 | US20110287086 Regeneration of Pancreatic Islets and Reversal of Diabetes by Islet Transcription Factor Genes Delivered in Vivo |
| 11/24/2011 | US20110287084 Method for reducing body fat and increasing lean body mass by reducing stearoyl-coa desaturase 1 activity |
| 11/24/2011 | US20110287071 Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs |
| 11/24/2011 | US20110287066 Nanoporous Foamed Active Compound-Containing Preparations Based On Pharmaceutically Acceptable Thermoplastically Workable Polymers |
| 11/24/2011 | US20110287065 Nanoparticulate cinacalcet compositions |
| 11/24/2011 | US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies |
| 11/24/2011 | US20110287049 Prevention and treatment of amyloidogenic diseases |
| 11/24/2011 | US20110287048 Antigen Specific Tregs and related compositions, methods and systems |
| 11/24/2011 | US20110287033 Use of ferritin to treat iron disorders |
| 11/24/2011 | US20110287030 Compositions and methods for diagnosing and treating an inflammation |
| 11/24/2011 | US20110287029 Inhibition of the beta3 subunit of l-type ca2+ channels |
| 11/24/2011 | US20110287026 Sirt4 and uses thereof |
| 11/24/2011 | US20110287023 High Affinity Antibodies Against HMGB1 and Methods of Use Thereof |
| 11/24/2011 | US20110286997 Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes |
| 11/24/2011 | US20110286995 Drug Therapy for Celiac Sprue |
| 11/24/2011 | US20110286994 Methods and compositions for improving growth of meat-type poultry |
| 11/24/2011 | US20110286993 Use of hsp70 as a regulator of enzymatic activity |
| 11/24/2011 | US20110286989 ANGIOGENIN COMPLEXES (ANGex) WITH LIPID-BASED SUBSTRATES AND USES THEREOF |
| 11/24/2011 | US20110286984 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases |
| 11/24/2011 | US20110286982 Glucagon analogues |
| 11/24/2011 | US20110286981 Glucagon analogues |
| 11/24/2011 | US20110286977 G6PC2-Encoded Beta Cell Surface Tags |
| 11/24/2011 | US20110286974 Method for treating diabetes and other glucose regulation disorders using stem cells |
| 11/24/2011 | US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use |
| 11/24/2011 | US20110286930 Methods of identifying modulators of the pp2a b56 beta regulatory subunit |
| 11/24/2011 | US20110286923 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases |
| 11/24/2011 | US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 11/24/2011 | CA2802931A1 Novel glucagon like peptide analogs, composition, and method of use |
| 11/24/2011 | CA2800161A1 Modulators of 5-ht receptors and methods of use thereof |
| 11/24/2011 | CA2799792A1 Inhibitors of human 12-lipoxygenase |
| 11/24/2011 | CA2799779A1 Piperidinyl-substituted lactams as gpr119 modulators |
| 11/24/2011 | CA2799733A1 New uses of oxytocin-like molecules and related methods |
| 11/24/2011 | CA2799708A1 2-phenyl benzoylamides |
| 11/24/2011 | CA2799559A1 Production of dha and other lc-pufas in plants |
| 11/24/2011 | CA2799480A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases |
| 11/24/2011 | CA2799414A1 Spiro isoxazoline compounds as sstr5 antagonists |
| 11/24/2011 | CA2798970A1 Pyrrolopyrazine derivatives as syk and jak inhibitors |
| 11/24/2011 | CA2792669A1 Long - acting formulations of insulins |
| 11/23/2011 | EP2388317A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases |
| 11/23/2011 | EP2388265A1 Compositions and methods for the treatment of immune related diseases |
| 11/23/2011 | EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators |
| 11/23/2011 | EP2388012A1 Kisspeptin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus |
| 11/23/2011 | EP2387572A2 Protein kinase c inhibitors and uses thereof |
| 11/23/2011 | EP2387412A1 Methods for increasing adiponectin |
| 11/23/2011 | EP2387406A1 Postprandial hyperglycemia-improving agent |
| 11/23/2011 | EP2387403A1 Method of treating cancer |
| 11/23/2011 | EP2387326A1 Companion animal compositions including pyruvic acid and salts thereof and methods of use thereof |